Dear ANDYJAMESH, According to AOP;s company announcement on the 10 july it states it wishes to advance its clinical therapeutic candidates including oral TNF blocker and oral insulin. Hopefully the company can raise the finances and get up and become a going concern. If the company can get the oral insulin clinical trials up and running and show that oral insulin works and is safe they will be onto a winner.Would have profound implications for the future management for diabetics and would revolutionise future treatment.
AOP Price at posting:
0.0¢ Sentiment: None Disclosure: Held
